Your browser doesn't support javascript.
Covid-19 pandemic in Egyptian children with liver diseases: Incidence and impact on health care service delivery in a low/middle income country.
Abdullatif, Hala; Elakel, Wafaa; Baroudy, Sherif; El-Karaksy, Hanaa; Mogahed, Engy A.
  • Abdullatif H; Department of Paediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Elakel W; Tropical Medicine Department, Cairo University and National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.
  • Baroudy S; Department of Paediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • El-Karaksy H; Department of Paediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Mogahed EA; Department of Paediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: engy.mogahed@kasralainy.edu.eg.
Arab J Gastroenterol ; 23(1): 1-6, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1620447
ABSTRACT
BACKGROUND AND STUDY

AIMS:

The coronavirus disease 2019 (COVID-19) pandemic has had considerable effects on health care services given the need for re-allocation of resources and interruption of medical care. COVID-19 poses a challenge to patients with liver disease who are at risk of infection and more severe disease course. The current study aimed to assess the incidence of COVID-19 in children with liver diseases and evaluate the extent to which health care delivery was affected during lockdown. PATIENTS AND

METHODS:

This cross-sectional analytical study conducted at the Pediatric Hepatology Unit, Cairo University Children's Hospital utilized a questionnaire to determine the incidence of COVID-19 in patients with liver diseases and the impact of COVID-19 on the patients' liver condition and health care service delivery. A presumed score was implemented to identify patients with probable COVID-19.

RESULTS:

Data from 349 children with liver diseases were analyzed. The overall incidence of COVID-19 was 8%. Patients with documented and probable COVID-19 were compared to improbable COVID-19 cases. Notably, COVID-19 cases were younger and had higher incidence rates of cholestatic liver diseases. COVID-19 patients experienced significantly higher rates of hepatic complications (43%) and had significantly greater need for medical services during the lockdown. All COVID-19 patients recovered after a median (IQR) duration of 3 (4) days, except for one patient who succumbed to COVID-19 and hepatic complications.

CONCLUSIONS:

COVID-19 affected the younger hepatic patients with cholestatic disorders of infancy. Hepatic complications were more common among COVID-19 infected children. Alternative ways of communication require development to prioritize patients who needs a hospital visit and monitoring. Clinical scores may help diagnosis of COVID-19 in low/middle income countries like Egypt to compensate for the deficient laboratory diagnostic facilities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Liver Diseases Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Child / Humans Country/Region as subject: Africa Language: English Journal: Arab J Gastroenterol Year: 2022 Document Type: Article Affiliation country: J.ajg.2022.01.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Liver Diseases Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Child / Humans Country/Region as subject: Africa Language: English Journal: Arab J Gastroenterol Year: 2022 Document Type: Article Affiliation country: J.ajg.2022.01.002